TG Therapeutics | Ativos

Assets Alterar Data
AbbVie USD 136.22B 854M 2023-09
Amgen USD 97.15B 6.62B 2023-12
Ardelyx USD 289.38M 78.18M 2023-09
Arrowhead Research USD 626.29M 139.27M 2023-12
Bayer EUR 117.24B 4.43B 2023-09
Corcept Therapeutics USD 621.52M 27.49M 2023-12
Dynavax Technologies USD 997.1M 24.16M 2023-12
Gilead Sciences USD 62.13B 248M 2023-12
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
TG Therapeutics USD 329.59M 1.48M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



TG Therapeutics Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.